Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Sales | 515 | 310 | 265 | 0 | 0 |
| Cost of Goods | 265 | 127 | 154 | N/A | N/A |
| Gross Profit | 250 | 182 | 112 | N/A | N/A |
| Operating Expenses | 7,035 | 3,849 | 4,577 | 2,893 | 3,306 |
| Operating Income | -6,520 | -3,540 | -4,312 | -2,893 | -3,306 |
| Other Income | -1,350 | 64 | 29 | -79 | 48 |
| Pre-tax Income | -7,870 | -3,476 | -4,283 | -2,972 | -3,259 |
| Net Income Continuous | -7,870 | -3,476 | -4,283 | -2,972 | -3,259 |
| Net Income | $-7,870 | $-3,476 | $-4,283 | $-2,972 | $-3,259 |
| EPS Basic Total Ops | -262.60 | -122.80 | -154.60 | -123.40 | -214.20 |
| EPS Basic Continuous Ops | -262.33 | -122.80 | -154.64 | -123.33 | -216.42 |
| EPS Diluted Total Ops | -262.60 | -122.80 | -154.60 | -123.40 | -214.20 |
| EPS Diluted Continuous Ops | -262.33 | -122.80 | -154.64 | -123.33 | -216.42 |
| EBITDA(a) | $-6,466 | $-3,486 | $-4,262 | $-2,864 | $-3,278 |